(19)
(11) EP 4 816 057 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817225.6

(22) Date of filing: 28.11.2024
(51) International Patent Classification (IPC): 
A61P 25/00(2006.01)
A61K 31/5517(2006.01)
C07D 487/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 487/04; A61P 25/00
(86) International application number:
PCT/EP2024/083843
(87) International publication number:
WO 2025/114404 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 EP 23213492

(71) Applicant: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventors:
  • BUTTAR, Suzanne Marie
    Edinburgh EH11 2QA (GB)
  • PATTERSON, Adam Ross
    Edinburgh EH11 2QA (GB)
  • STRATFORD, Samuel Alexander
    Edinburgh EH11 2QA (GB)

(74) Representative: Graham Watt & Co 
Fulwood House 12 Fulwood Place
London WC1V 6HR
London WC1V 6HR (GB)

   


(54) SOLID FORMS OF A PHARMACEUTICALLY ACTIVE COMPOUND